MRO Cost & Pricing Analysis 2 — Questions and Answers
Question 1: Under DOT regulations, who is financially responsible for the cost of a DOT-required return-to-duty drug test?
- The employee
- The employer (Correct answer)
- The MRO
- The collection site
Correct answer: The employer
The employer bears the cost of all DOT-mandated testing, including return-to-duty tests.
Question 2: A split specimen (Bottle B) retest is requested by the donor. Which party typically pays the initial cost of the retest?
- The MRO pays upfront
- The employer pays upfront
- The donor pays upfront and may be reimbursed if confirmed negative (Correct answer)
- The laboratory pays upfront
Correct answer: The donor pays upfront and may be reimbursed if confirmed negative
The donor must pay for the split specimen retest upfront, but if the result is reported negative or invalid, the employer must reimburse the donor.
Question 3: Which cost component is typically EXCLUDED from a standard MRO review fee quoted to employers?
- Review of chain of custody documentation
- Direct communication with the donor
- Laboratory specimen analysis fees (Correct answer)
- Reporting results to the DER
Correct answer: Laboratory specimen analysis fees
Laboratory specimen analysis fees are billed separately by the laboratory and are not included in the MRO review fee.
Question 4: When an employer contracts with a Third Party Administrator (TPA) for drug testing services, the TPA fee structure most commonly includes:
- Only collection fees
- Only MRO fees
- Bundled collection, laboratory, and MRO fees at a negotiated rate (Correct answer)
- Only laboratory fees
Correct answer: Bundled collection, laboratory, and MRO fees at a negotiated rate
TPAs typically bundle collection, laboratory, and MRO services into a single per-test price through volume negotiation.
Question 5: An MRO practice wishes to offer volume discounts to large trucking fleets. Under DOT regulations, this practice is:
- Prohibited because it creates a conflict of interest
- Permitted as long as it does not compromise the integrity of MRO determinations (Correct answer)
- Permitted only if approved by SAMHSA
- Prohibited because all employers must pay the same rate
Correct answer: Permitted as long as it does not compromise the integrity of MRO determinations
Volume discounts are permissible provided the fee arrangement does not compromise the MRO's independent judgment or integrity.
Question 6: Which of the following scenarios would constitute a prohibited financial arrangement for an MRO?
- Charging a flat per-test review fee
- Receiving a percentage of the laboratory's revenue for specimens reviewed (Correct answer)
- Offering a reduced rate for long-term employer contracts
- Billing separately for verified positive reviews
Correct answer: Receiving a percentage of the laboratory's revenue for specimens reviewed
An MRO receiving a percentage of laboratory revenue creates a financial incentive that could compromise independent determinations.
Question 7: What is the primary reason DOT prohibits MROs from having a financial interest in the laboratory that analyzes specimens they review?
- To reduce employer costs
- To prevent conflicts of interest that could bias MRO determinations (Correct answer)
- To simplify billing procedures
- To ensure laboratory accreditation compliance
Correct answer: To prevent conflicts of interest that could bias MRO determinations
Financial ties between an MRO and the testing laboratory could bias the MRO toward accepting laboratory results that benefit both financially.
MRO Cost & Pricing Analysis 2
Under DOT regulations, who is financially responsible for the cost of a DOT-required return-to-duty drug test?